Recruitment

Recruitment Status
Completed
Estimated Enrollment
60

Inclusion Criteria

patients undergoing major urological surgical procedures performed by laparotomy
signed informed consent
patients undergoing major abdominal surgical procedures performed by laparotomy
...
patients undergoing major urological surgical procedures performed by laparotomy
signed informed consent
patients undergoing major abdominal surgical procedures performed by laparotomy
patients undergoing major gynecological surgical procedures performed by laparotomy
age ≥ 18 years

Exclusion Criteria

presence of an arterio-venous shunt or of any other vascular disease on upper limb
pregnant women
beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,
...
presence of an arterio-venous shunt or of any other vascular disease on upper limb
pregnant women
beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,
allergy to gelatin
aortic valve disease
esophageal disease
BMI > 35

Summary

Conditions
Fluid Responsiveness
Type
Interventional
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Supportive Care

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

patients undergoing major urological surgical procedures performed by laparotomy
signed informed consent
patients undergoing major abdominal surgical procedures performed by laparotomy
...
patients undergoing major urological surgical procedures performed by laparotomy
signed informed consent
patients undergoing major abdominal surgical procedures performed by laparotomy
patients undergoing major gynecological surgical procedures performed by laparotomy
age ≥ 18 years

Exclusion Criteria

presence of an arterio-venous shunt or of any other vascular disease on upper limb
pregnant women
beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,
...
presence of an arterio-venous shunt or of any other vascular disease on upper limb
pregnant women
beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,
allergy to gelatin
aortic valve disease
esophageal disease
BMI > 35

Tracking Information

NCT #
NCT02040948
Collaborators
Not Provided
Investigators
Not Provided